Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
210,587,372
-
Total 13F shares
-
34,819,131
-
Share change
-
+98,070
-
Total reported value
-
$264,754,100
-
Put/Call ratio
-
54%
-
Price per share
-
$7.60
-
Number of holders
-
76
-
Value change
-
+$745,210
-
Number of buys
-
4
-
Number of sells
-
1
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q4 2013
As of 31 Dec 2013,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,819,131 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT CO LLP, RA CAPITAL MANAGEMENT, LLC, FMR LLC, D. E. Shaw & Co., Inc., VHCP Management, LLC, VANGUARD GROUP INC, TPG Group Holdings (SBS) Advisors, Inc., BlackRock Institutional Trust Company, N.A., and DEERFIELD MANAGEMENT CO.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.